The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM statement

9 Apr 2020 07:00

RNS Number : 2729J
Location Sciences Group PLC
09 April 2020
 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

AGM Statement

 

Location Sciences (AIM: LSAI), the leading location data verification company, is holding its Annual General Meeting ("AGM") at 9.00am today at 20 Eastbourne Terrace, Paddington London W2 6LG. Ahead of the formal business of the AGM, Kelvin Harrison, Non-Executive Chairman of Location Sciences, will make the following statement:.

 

"The COVID-19 pandemic is having a significant impact on businesses across the world and Location Sciences, while being a software company, is not immune to these effects. While half of our revenues are fixed monthly fees, and therefore relatively secure, the other half are based on the volume of location advertising.

 

"Location Sciences' existing customer base is largely within the QSR (quick service restaurants), retail and leisure sectors, which have all been significantly impacted by the UK Government's restrictions. Consequently, while Q1 performance was in-line with the Board's expectations, the Directors anticipate Q2 revenues to be lower than previously expected. However, the Company's annual revenues are typically heavily weighted towards Q4, therefore the Directors expect to recover some of those Q2 lost revenues as brands seek to make up lost ground in the latter part of 2020.

 

"Shareholders should take comfort that, as a cloud-based software business, Location Sciences, which operates in four locations globally, has not seen a material impact on its core operations or services. It is well placed to act on the opportunities it sees in the marketplace.

 

"One such opportunity is to use the Company's location technology and considerable knowhow to assist the UK Government in understanding the effects of its policies, as well as to be part of any track and trace COVID-19 solution. The Directors are actively working with the Company's partners, and reaching out directly to the UK Government, to inform its decision making. The ultimate aim is to be part of a technology solution to supress the spread of COVID-19 while allowing some form of normality to return to the economy and to everyday lives. The Directors will keep shareholders updated on any material developments in this regard.

 

"With Q2 revenues likely to be lower than previously expected, the Company has also undertaken certain cost cutting measures. These include putting the Company's marketing and business development budgets on hold until there is greater visibility on when revenues are expected to return to normal levels. There is also considerable effort going into product development, which runs alongside our MRC accreditation process. Consequently, our engineering teams have never been busier. Since the year end, the Company has moved some of its engineering and data science team to the Ukraine, which gives us access to high calibre talent at competitive rates, as well as a degree of flexibility when demand increases for customer deliverables. In combination with the rationalisation programme undertaken in H2 2019, there are now only 16 full time staff serving four global locations. The Directors will monitor the need for more cost cutting depending on how long it takes for revenues to return to previous levels.

 

"Lastly, and on a personal note, while the impact of the COVID-19 pandemic has been felt by businesses globally, the personal impact of those affected is by far the most significant. It is with great sadness that I report that one of our longstanding shareholders passed away from the virus on Monday. All our thoughts are with his family and friends at this time. Please take care and heed the Government's advice; by all pulling in the same direction we will get through this together."

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

 

Shore Capital (Nomad and Joint Broker)

 

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 

About Location Sciences

Location Sciences is the pre-eminent global location verification provider to the $190 billion digital advertising industry, working in partnership with brands, media agencies and suppliers to reduce ad wastage and improve the effectiveness of location-based advertising campaigns.

The digital advertising marketplace remains unregulated and unmonitored, with an estimated $19 billion wasted on ad fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUWSVRRWUSRAR
Date   Source Headline
1st Jun 20207:00 amRNSIssue of Equity and Total Voting Rights
11th May 20201:51 pmRNSHolding(s) in Company
11th May 20201:50 pmRNSHolding(s) in Company
7th May 20202:06 pmRNSSecond Price Monitoring Extn
7th May 20202:00 pmRNSPrice Monitoring Extension
6th May 202010:42 amRNSIssue of Equity and Total Voting Rights
1st May 20202:06 pmRNSSecond Price Monitoring Extn
1st May 20202:00 pmRNSPrice Monitoring Extension
29th Apr 202011:06 amRNSSecond Price Monitoring Extn
29th Apr 202011:01 amRNSPrice Monitoring Extension
20th Apr 20203:16 pmRNSIssue of Equity and Total Voting Rights
9th Apr 202012:17 pmRNSResult of AGM
9th Apr 20207:00 amRNSAGM statement
8th Apr 202010:11 amRNSHolding(s) in Company
3rd Apr 20202:06 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSAttendance at the Company’s AGM
1st Apr 20204:45 pmRNSHolding(s) in Company
31st Mar 202010:12 amRNSHolding(s) in Company
31st Mar 202010:10 amRNSHolding(s) in Company
26th Mar 202011:50 amRNSResult of GM, Appointment of Joint Broker and TVR
26th Mar 20207:00 amRNSIssue of Warrants
23rd Mar 202012:00 pmRNSCovid-19 Update
16th Mar 20203:33 pmRNSNotice of GM
16th Mar 20207:00 amRNSAnnual Financial Report
6th Mar 20204:04 pmRNSConditional Placing and Share Re-organisation
3rd Mar 20207:00 amRNSGlobal Master Service Agreement and Partnership
28th Feb 20202:05 pmRNSSecond Price Monitoring Extn
28th Feb 20202:00 pmRNSPrice Monitoring Extension
26th Feb 20202:51 pmRNSStatement Regarding Share Price Movement
24th Jan 202010:09 amRNSHolding(s) in Company
23rd Jan 20207:00 amRNSReport: The State of Privacy & Location Marketing
20th Jan 202011:41 amRNSIssue of Equity and Total Voting Rights
15th Jan 20202:00 pmRNSTrading Update and Partnership with X-Mode
17th Dec 20199:00 amRNSHolding(s) in Company
17th Dec 20198:56 amRNSHolding(s) in Company
12th Nov 20192:45 pmRNSMello London 2019 Presentation
28th Oct 201911:00 amRNSLocation Sciences to present at Mello London 2019
28th Oct 20198:57 amRNSLocation Sciences to present at Mello London 2019
7th Oct 20194:12 pmRNSHolding(s) in Company
7th Oct 20194:09 pmRNSHolding(s) in Company
27th Sep 201911:18 amRNSResult of Placing
26th Sep 20196:24 pmRNSUpdate re Placing
26th Sep 20197:01 amRNSProposed Placing
26th Sep 20197:00 amRNSHalf-year Report
16th Sep 20197:00 amRNSContract with Vicinity Media
5th Sep 20197:00 amRNSPartnership with Blis
2nd Sep 20199:29 amRNSAdvisory Panel Appointment
1st Aug 20198:31 amRNSTrading Update and Appointment
15th Jul 20197:00 amRNSLocation Sciences appoints Andy Roberts
24th Jun 20191:38 pmRNSDirector's Disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.